APA (7th ed.) Citation

HD, R., MJ, C., EJ, D., Y, Z., KW, T., MI, S., . . . KK, L. (2016). Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devices. Gynecologic oncology, 140(1), 152. https://doi.org/10.1016/j.ygyno.2015.10.023

Chicago Style (17th ed.) Citation

HD, Reyes, et al. "Downregulation of FOXO1 MRNA Levels Predicts Treatment Failure in Patients with Endometrial Pathology Conservatively Managed with Progestin-containing Intrauterine Devices." Gynecologic Oncology 140, no. 1 (2016): 152. https://doi.org/10.1016/j.ygyno.2015.10.023.

MLA (9th ed.) Citation

HD, Reyes, et al. "Downregulation of FOXO1 MRNA Levels Predicts Treatment Failure in Patients with Endometrial Pathology Conservatively Managed with Progestin-containing Intrauterine Devices." Gynecologic Oncology, vol. 140, no. 1, 2016, p. 152, https://doi.org/10.1016/j.ygyno.2015.10.023.